Welcome to the
CF AMR Syndicate
Who are we?
In 2019, Medicines Discovery Catapult joined forces with Cystic Fibrosis Trust to form the Cystic Fibrosis Syndicate in Antimicrobial Resistance. The Syndicate expanded, welcoming LifeArc in a tripartite managing partnership. The CF Syndicate in AMR is a cross-sector initiative that brings together leading experts in CF/AMR from industry, academia, and the clinic with people with Cystic Fibrosis.
